A Conversation About the FDA's Regulation of Mifepristone
JAMA Clinical Reviews
00:00
Why mifepristone's regulation is unique
Alexander describes REMS, contextual safety, and how mifepristone's political scrutiny made its regulation atypical.
Play episode from 02:12
Transcript


